Event description: - Suzhou: September 5, 14:00–17:00 at BioBay.
- Beijing: September 8, 14:00–16:30 at ZGC Life Science Park.
Novotech and Linear have partnered to lead a two-city roadshow in China, showcasing how Australia’s regulatory and clinical environment can accelerate global development for Chinese biotech sponsors.
The itinerary for both sessions will include:
- 14:05 – 14:30 Gab Silver (Novotech) will discuss Australia’s streamlined trial environment, global data acceptance, and cost advantages.
- 14:30 – 14:55 Jayden Rogers (Linear) will present how Phase I clinical sites drive success through design, recruitment, and execution.
- 14:55 – 15:20 Kylie Sproston (Bellberry) will outline the CTN scheme, regulatory framework, and ethics review process.
- 15:45 – 16:05 Kenny Chen (Acclime) will cover R&D incentives and strategic planning for conducting trials in Australia.
- Interactive fireside chat to conclude the event.
All sessions are tailored for biotech sponsors, CROs, and research organizations seeking faster, cost-effective global trial pathways.
Schedule a meeting through the form on this page to learn how Novotech and its partners can accelerate your Phase I strategy and help you achieve your next milestone.
